Page last updated: 2024-12-11

capsiate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9839519
CHEBI ID134190
SCHEMBL ID1585964
MeSH IDM0444611

Synonyms (25)

Synonym
CHEBI:134190
205687-01-0
(4-hydroxy-3-methoxyphenyl)methyl (6e)-8-methylnon-6-enoate
vanillyl (6e)-8-methylnon-6-enoate
6-nonenoic acid, 8-methyl-, (4-hydroxy-3-methoxyphenyl)methyl ester, (6e)-
capsiate ,
px8i7hg5i3 ,
unii-px8i7hg5i3
capsiate natura
6-nonenoic acid, 8-methyl-, (4-hydroxy-3-methoxyphenyl)methyl ester, (e)-
C20203
SCHEMBL1585964
vanillyl trans-8-methyl-non-6-enoate
AKOS025147159
DTXSID20174575
4-hydroxy-3-methoxybenzyl 8-methyl-6-nonenoate
(e)-4-hydroxy-3-methoxybenzyl 8-methylnon-6-enoate
(4-hydroxy-3-methoxyphenyl)methyl (e)-8-methylnon-6-enoate
ZICNYIDDNJYKCP-SOFGYWHQSA-N
Q27286800
(e)-4-hydroxy-3-methoxybenzyl8-methylnon-6-enoate
CS-0143769
HY-N8377
E88102
(6e)-8-methyl-6-nonenoic acid (4-hydroxy-3-methoxyphenyl)methyl ester

Research Excerpts

Overview

Capsiate is a capsaicin-like ingredient of a non-pungent cultivar of red pepper, CH-19 sweet.

ExcerptReferenceRelevance
"Capsiate is a non-pungent analogue of capsaicin. "( Sweet pepper and its principle constituent capsiate: functional properties and health benefits.
Awasthi, A; Gulati, M; Gupta, M; Gupta, R; Kapoor, B; Kumar, B; Singh, SK, 2022
)
2.43
"Capsiate is a non-pungent analogue of capsaicin from CH-19 Sweet peppers. "( Beneficial effects of capsiate on ethanol-induced mucosal injury in rats are related to stimulation of calcitonin gene-related Peptide release.
Dai, Z; Li, NS; Liu, B; Luo, XJ; Peng, J; Yang, ZC; Zhang, YS, 2012
)
2.14
"Capsiate is a capsaicin-like ingredient of a non-pungent cultivar of red pepper, CH-19 sweet. "( TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate.
Fushiki, T; Hashizume, S; Iida, T; Kobata, K; Morita, A; Moriyama, T; Murayama, N; Tominaga, M; Watanabe, T; Yazawa, S, 2003
)
1.98
"Capsiate is a nonpungent capsaicin analog, a recently identified principle of the nonpungent red pepper cultivar CH-19 Sweet. "( Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog.
Fushiki, T; Haramizu, S; Hashizume, S; Kawada, T; Masuda, Y; Ohnuki, K; Oki, K; Watanabe, T; Yazawa, S, 2003
)
2

Effects

ExcerptReferenceRelevance
"Capsiate has been identified and quantified in some varieties of peppers."( Use of multivariate statistical techniques to optimize the separation of 17 capsinoids by ultra performance liquid chromatography using different columns.
Avellán, OF; Barbero, GF; Barroso, CG; Coutinho, JP; Garcés-Claver, A; Godoy, HT; Palma, M, 2015
)
1.14

Actions

ExcerptReferenceRelevance
"Capsiate is known to increase whole body oxygen consumption possibly via the activation of uncoupling processes, but its effect at the skeletal muscle level remains poorly documented and conflicting. "( A single intake of capsiate improves mechanical performance and bioenergetics efficiency in contracting mouse skeletal muscle.
Bendahan, D; Bernard, M; Dalmasso, C; Fur, YL; Giannesini, B; Kazuya, Y; Pecchi, E; Tonson, A; Vilmen, C, 2014
)
2.17

Treatment

Capsiate-pretreated human keratinocytes inhibited intracellular reactive oxygen species (ROS), which activate the mitogen-activated protein kinase and nuclear factor-kappaB pathways. The treatment with capsiate or placebo for 8 weeks was not associated with significant changes in weight or waist circumference.

ExcerptReferenceRelevance
"Capsiate treatment interfered with hepatic parameters, reducing the number of mitoses and apoptosis and increasing blood ALT and alkaline phosphatase concentrations."( Capsiate treatment in liver surgeries may compromise its recovery.
Barros, PP; Bastos, MCVD; Fernandes, MM; Gonçalves, GMS; Ramos, LN; Silva, GHD, 2018
)
3.37
"Capsiate treatment preceding hepatic surgery may compromise the initial period of postoperative recovery."( Capsiate treatment in liver surgeries may compromise its recovery.
Barros, PP; Bastos, MCVD; Fernandes, MM; Gonçalves, GMS; Ramos, LN; Silva, GHD, 2018
)
3.37
"Both capsiate treatments further promoted muscle mass gain, and the higher dose also reduced body weight gain and abdominal fat content."( Capsiate supplementation reduces oxidative cost of contraction in exercising mouse skeletal muscle in vivo.
Bendahan, D; Bernard, M; Giannesini, B; Le Fur, Y; Pecchi, É; Tonson, A; Vilmen, C; Yashiro, K, 2015
)
2.31
"Capsiate-pretreated human keratinocytes inhibited intracellular reactive oxygen species (ROS), which activate the mitogen-activated protein kinase and nuclear factor-kappaB (NF-kappaB) pathways."( Capsiate inhibits ultraviolet B-induced skin inflammation by inhibiting Src family kinases and epidermal growth factor receptor signaling.
Jeon, MS; Kim, BD; Kim, JH; Kim, TY; Kwon, YG; Lee, EJ; Lee, H; Lee, YS; Yang, JH, 2010
)
2.52
"The treatment with capsiate or placebo for 8 weeks was not associated with significant changes in weight or waist circumference."( Gender-specific effects of capsiate supplementation on body weight and bone mineral density: a randomized, double-blind, placebo-controlled study in slightly overweight women.
Baldini, V; Balercia, G; Basili, S; Cinti, S; Giordano, A; Paolini, S; Petrelli, M; Salvio, G; Sbaffi, C, 2023
)
1.53
"Treatment with capsiate for 8 weeks led to negligible changes in body weight in a small sample of slightly overweight women, but our findings suggest a potential effect of capsaicin on bone metabolism in humans."( Gender-specific effects of capsiate supplementation on body weight and bone mineral density: a randomized, double-blind, placebo-controlled study in slightly overweight women.
Baldini, V; Balercia, G; Basili, S; Cinti, S; Giordano, A; Paolini, S; Petrelli, M; Salvio, G; Sbaffi, C, 2023
)
1.56
"Treatment with capsiate inhibited the expression of pro-inflammatory cytokines and degranulation from activated bone marrow-derived mast cells through the inhibition of extracellular signal-regulated kinase signal pathways."( Capsiate Inhibits DNFB-Induced Atopic Dermatitis in NC/Nga Mice through Mast Cell and CD4+ T-Cell Inactivation.
Kim, TY; Lee, EJ; Lee, JH; Lee, YS, 2015
)
2.2

Toxicity

Dihydrocapsiate was 1000 mg/kg/day for both male and female rats in this 13-week gavage study. It was concluded that the no observed adverse effect level (NOAEL) of dihydrocapsiates was 300 mg/ kg/ day for male rats.

ExcerptReferenceRelevance
" It was concluded that the no observed adverse effect level (NOAEL) of dihydrocapsiate was 1000 mg/kg/day for both male and female rats in this 13-week gavage study."( Studies of the toxicological potential of capsinoids: VII. A 13-week toxicity study of dihydrocapsiate in rats.
Bernard, BK; Kodama, T; Masuyama, T; Mochizuki, M; Otabe, A; Tsubuku, S; Watanabe, E, 2008
)
0.79
" It was concluded that the no observed adverse effect level (NOAEL) of dihydrocapsiate was 300 mg/kg/day for male rats and 1000 mg/kg/day for female rats in this 13 week gavage study."( Studies of the toxicological potential of capsinoids: VIII. A 13-week toxicity study of commercial-grade dihydrocapsiate in rats.
Bernard, BK; Kodama, T; Masuyama, T; Mochizuki, M; Otabe, A; Tsubuku, S; Watanabe, E, 2008
)
0.79
" There were no adverse or toxicological changes observed in clinical signs, body weight, food consumption, water intake, ophthalmology, urinalysis, hematology, blood chemistry, organ weights, or histopathology."( Studies of the toxicological potential of capsinoids XIV: a 26-week gavage toxicity study of dihydrocapsiate in rats.
Bernard, BK; Kayahara, T; Kodama, T; Masuyama, T; Ohishi, T; Tsubuku, S; Wagner, BM, 2010
)
0.58

Bioavailability

ExcerptReferenceRelevance
" However, some reports have shown that anthocyanin is poorly absorbed in the small intestine."( Intestinal absorption of black chokeberry cyanidin 3-glycosides is promoted by capsaicin and capsiate in a rat ligated small intestinal loop model.
Chiji, H; Higuchi, O; Sakaguchi, H; Suzuki, T; Takahashi, A, 2019
)
0.73

Dosage Studied

ExcerptRelevanceReference
" After the end of the dosing period, reversibility was assessed (10/sex/group for the control and 1000 mg/kg groups) following a 4-week recovery period."( Studies of the toxicological potential of capsinoids XIV: a 26-week gavage toxicity study of dihydrocapsiate in rats.
Bernard, BK; Kayahara, T; Kodama, T; Masuyama, T; Ohishi, T; Tsubuku, S; Wagner, BM, 2010
)
0.58
" Discussed also are potential future directions for formulation strategies to develop efficient, safe and cost-effective dosage forms of capsiate to explore its role in various disease conditions."( Sweet pepper and its principle constituent capsiate: functional properties and health benefits.
Awasthi, A; Gulati, M; Gupta, M; Gupta, R; Kapoor, B; Kumar, B; Singh, SK, 2022
)
1.19
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
hypoglycemic agentA drug which lowers the blood glucose level.
anti-allergic agentA drug used to treat allergic reactions.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
angiogenesis inhibitorAn agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
capsaicin receptor agonistAn agonist that binds to and activates capsaicin receptors
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
carboxylic esterAn ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.
monomethoxybenzeneCompounds containing a benzene skeleton substituted with one methoxy group.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (66)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's19 (28.79)29.6817
2010's35 (53.03)24.3611
2020's12 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.29 (24.57)
Research Supply Index4.32 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index99.17 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (36.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (10.45%)5.53%
Reviews4 (5.97%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other56 (83.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]